THE AMAZING (NEURO) RACE IS ON On Sunday, April 24, 2016, The Neuro will be participating once again in the Scotiabank Charity Challenge! This annual fundraising event, held in conjunction with the Banque Scotia 21k de Montréal et 5k, allows participants to raise funds in support The Neuro. Over 6,000 runners and representatives from over 60 charities will be in attendance for the 2016 installment of one of the biggest races in Quebec.
The Tony Proudfoot Training Fellowship in ALS research at the Montreal Neurological Institute and Hospital supports promising young scientists at the master’s, doctoral and post-doctoral level who wish to undertake research projects that specifically focus on ALS. This year, the winner of the Tony Proudfoot Fellowship is Dr. Audrey Dangoumau. Audrey recently completed her PhD thesis under the supervision of Pr. Patrick Vourc’h at the University of Tours, in France. Her PhD research revealed the importance of SUMOylation in the formation of aggregates with SOD1 mutation.
It is now official, as announced in today's issue of Science magazine: the MNI is becoming the first ever Open-Science academic institution. The BIC has already been active in multiple data-sharing and open-source software initiatives.
The Neuro receives support from Montreal-based Vigilant Global for the development of first chemical brain atlas
The Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the McGill University Health Centre, today announced a significant donation from Montreal-based technology firm Vigilant Global that will enable the development of the world’s first chemical brain atlas. The Neuro team, led by neurosurgeon and research scientist Dr.
Researchers at the Montreal Neurological Institute explore why learning a second language is easier for some people Learning a second language is easier for some adults than others, and innate differences in how the various parts of the brain “talk” to one another may help explain why, according to a new study led by Chai Xiaoqian and Denise Klein, researchers at the Montreal Neurological Institute and Hospital, The Neuro at McGill University. The study was published January 20 in The Journal of Neuroscience.
We are happy to announce that Dr. David Rudko is joining the BIC’s MRI Unit as the Research Assistant (part-time) in charge of the 7-T small animal MRI operations. If you are interested in accessing the scanner, please contact David david [dot] rudko [at] mcgill [dot] ca (directly). David is also a Postdoctoral Fellow with Drs. Arnold and Narayanan, funded by a fellowship from the Multiple Sclerosis Society of Canada and the CIHR Neuroinflammation Training Program.
Scientists at the Montreal Neuro shed light on little-studied part of the brain MONTREAL---If you’re pondering whether to buy a Galaxy smartphone or an iPhone this holiday season, a part of the brain called the dorsomedial prefrontal cortex (PFC) might ultimately determine your choice. Results of a new study by Avinash Vaidya and Dr. Lesley Fellows, researchers at the Montreal Neurological Institute and Hospital (The Neuro), suggest that this region of the brain plays a critical role in making choices.
We are very pleased to announce that the BIC continues to grow, with the recruitment of an MRI Physicist at the Assistant Professor level. Please refer to the recruitment ad for details.
MNI researchers share new tool with scientists world-wide to accelerate research MONTREAL---A new detailed map of the hippocampal region of the brain, compiled by researchers at the Montreal Neurological Institute and Hospital-The Neuro at McGill University, is helping the scientific community accelerate research and develop better treatments for patients suffering from epilepsy and other neurological and psychiatric disorders.
Scientists and Clinicians at The Montreal Neurological Institute and Hospital receive funding for ALS research
The ALS Ice Bucket Challenge One Year Later On November 19 2015, marking the anniversary of the announcement of the 2014 ALS Ice Bucket Challenge results and partnership between ALS Canada and Brain Canada, ALS Canada was at The Montreal Neurological Institute and Hospital – The Neuro, to announce the final recipients of their 2015 grant competition. Four researchers and clinicians at The Neuro were among those recipients for their groundbreaking work in the ALS research field.
Parkinson's disease: a new tool for health care professionals aims to improve diagnosis and advance treatment
The results of their study, published in the journal Movement Disorders. A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society (MDS), have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson’s disease, especially in the early stages. The results of their study, published in the journal Movement Disorders, could also have a major impact on the quality of research on Parkinson’s disease.
Today marks the 4500th day of faithful beaming in our IBA Cyclotron, Serial Number 000. The cyclotron is the pivotal instrument for producing isotopes used in radionuclides for PET and SPECT research at the Neuro.
The hippocampus has been a focus of neuroscience research for decades for its role in cognitive processes, as well as being a hallmark of prevalent neurological and psychiatric conditions, such as epilepsy, Alzheimer’s disease, depression, and schizophrenia. Identification of hippocampal subregions in vivo is thus essential for precise localization of function and pathology.
The MUHC’s secondary and tertiary stroke care programs bring together multidisciplinary experts, the latest in scientific advances, and state of the art equipment to provide world-class treatment, reducing death rates and long-term disability. Every 10 minutes, a Canadian suffers a stroke. It is the third leading cause of death in Canada with about 14,000 Canadian dying of stroke each year.
A new study led by researchers at the Montreal Neurological Institute and Hospital of McGill University and the MUHC, gets closer to identifying the mechanisms responsible for multiple sclerosis and makes headway in the search for better treatments.